FBIO – fortress biotech, inc. (US:NASDAQ)
Stock Stats
News
Fortress Biotech's Cyprium enters agreement to sell PRV for $205M [Yahoo! Finance]
Fortress Biotech (NASDAQ:FBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million [Yahoo! Finance]
UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million [Yahoo! Finance]
Form 8-K Fortress Biotech, Inc. For: Feb 22
Form 8-K Fortress Biotech, Inc. For: Jan 13
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Klein Dov
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Lorenz Kevin
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: LOBELL J JAY
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.